Published in J Psychiatr Res on April 20, 2012
Meta-analysis of oxidative stress in schizophrenia. Biol Psychiatry (2013) 1.27
A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry (2016) 0.99
Inflammation and the two-hit hypothesis of schizophrenia. Neurosci Biobehav Rev (2013) 0.98
Oxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward mitochondria-targeted clinical strategies. Oxid Med Cell Longev (2014) 0.95
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders. BMC Med (2015) 0.94
Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia. Dev Neurosci (2013) 0.87
Impaired metabolic reactivity to oxidative stress in early psychosis patients. Schizophr Bull (2014) 0.85
Evidence for disturbed insulin and growth hormone signaling as potential risk factors in the development of schizophrenia. Transl Psychiatry (2014) 0.82
From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways. Mol Psychiatry (2016) 0.82
Decreased serum TNF-alpha levels in chronic schizophrenia patients on long-term antipsychotics: correlation with psychopathology and cognition. Psychopharmacology (Berl) (2014) 0.81
Proteomic profiling in schizophrenia: enabling stratification for more effective treatment. Genome Med (2013) 0.78
Greater extracellular free-water in first-episode psychosis predicts better neurocognitive functioning. Mol Psychiatry (2017) 0.76
Relationship of serum levels of TNF-α, IL-6 and IL-18 and schizophrenia-like symptoms in chronic ketamine abusers. Schizophr Res (2015) 0.76
Higher Plasma S100B Concentrations in Schizophrenia Patients, and Dependently Associated with Inflammatory Markers. Sci Rep (2016) 0.75
Inflammation in Schizophrenia: Cytokine Levels and Their Relationships to Demographic and Clinical Variables. Am J Geriatr Psychiatry (2016) 0.75
Evaluation of Oxidant/Antioxidant Status and Cytokine Levels in Patients with Cannabis Use Disorder. Clin Psychopharmacol Neurosci (2017) 0.75
Serum fatty acid patterns in patients with schizophrenia: a targeted metabonomics study. Transl Psychiatry (2017) 0.75
A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy. Am Heart J (2007) 2.01
Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.78
Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J Psychiatr Res (2011) 1.71
Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord (2008) 1.46
The impact of a history of psychotic symptoms on cognitive function in euthymic bipolar patients: a comparison with schizophrenic patients and healthy controls. Rev Bras Psiquiatr (2011) 1.46
Clinical staging in psychiatry: a cross-cutting model of diagnosis with heuristic and practical value. Br J Psychiatry (2013) 1.43
Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci Lett (2006) 1.34
Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother (2009) 1.26
Altered oxygen metabolism associated to neurogenesis of induced pluripotent stem cells derived from a schizophrenic patient. Cell Transplant (2012) 1.17
Serum S100B and antioxidant enzymes in bipolar patients. J Psychiatr Res (2006) 1.17
Association of the gene encoding neurogranin with schizophrenia in males. J Psychiatr Res (2006) 1.16
Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode. Biol Psychiatry (2006) 1.16
Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: a systematic review and meta-analysis. J Clin Psychiatry (2008) 1.14
Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force. Aust N Z J Psychiatry (2013) 1.12
Low plasma brain-derived neurotrophic factor and childhood physical neglect are associated with verbal memory impairment in major depression--a preliminary report. Biol Psychiatry (2008) 1.11
Peripheral biomarkers and illness activity in bipolar disorder. J Psychiatr Res (2010) 1.10
[Performance of the Self-Reporting Questionnaire as a psychiatric screening questionnaire: a comparative study with Structured Clinical Interview for DSM-IV-TR]. Cad Saude Publica (2008) 1.09
Bioassay-guided evaluation of antioxidant and antinociceptive activities of carvacrol. Basic Clin Pharmacol Toxicol (2010) 1.09
Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder. Expert Rev Neurother (2008) 1.09
Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2008) 1.08
Delusional parasitosis or Ekbom syndrome: a case series. Gen Hosp Psychiatry (2005) 1.06
Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine. J Clin Psychiatry (2009) 1.05
Perspectives for the development of animal models of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry (2004) 1.04
Increased soluble tumor necrosis factor-alpha receptors in patients with major depressive disorder. Psychiatry Clin Neurosci (2009) 1.03
Mediators of allostasis and systemic toxicity in bipolar disorder. Physiol Behav (2011) 1.03
Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance. Rev Bras Psiquiatr (2011) 1.03
A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania. J Clin Psychiatry (2008) 1.02
Traumatic life events in bipolar disorder: impact on BDNF levels and psychopathology. Bipolar Disord (2007) 1.01
Therapeutic use of omega-3 fatty acids in bipolar disorder. Expert Rev Neurother (2011) 0.99
Characterization of blood oxidative stress in type 2 diabetes mellitus patients: increase in lipid peroxidation and SOD activity. Oxid Med Cell Longev (2012) 0.99
Inflammation biomarkers and delirium in critically ill patients. Crit Care (2014) 0.98
Reduced serum nerve growth factor in patients with late-life depression. Am J Geriatr Psychiatry (2013) 0.98
Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder. Neurosci Lett (2007) 0.98
Platelet-activating factor receptor is essential for the development of experimental cerebral malaria. Am J Pathol (2011) 0.97
3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. J Psychiatry Neurosci (2009) 0.97
Clinical staging in bipolar disorder: focus on cognition and functioning. J Clin Psychiatry (2014) 0.96
Effects of gabapentin on anxiety induced by simulated public speaking. J Psychopharmacol (2003) 0.96
DNA damage in bipolar disorder. Psychiatry Res (2007) 0.96
Neurocognitive functioning in patients with bipolar I disorder recently recovered from a first manic episode. J Clin Psychiatry (2010) 0.95
Interplay between neuroimmunoendocrine systems during post-traumatic stress disorder: a minireview. Neuroimmunomodulation (2010) 0.95
Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients. J Psychiatr Res (2009) 0.94
Intracerebral infection with dengue-3 virus induces meningoencephalitis and behavioral changes that precede lethality in mice. J Neuroinflammation (2011) 0.94
Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach. World J Biol Psychiatry (2013) 0.93
Frequency of social phobia and psychometric properties of the Liebowitz social anxiety scale in Parkinson's disease. Mov Disord (2008) 0.93
Chagas disease: independent risk factor for stroke. Stroke (2009) 0.92
Reduced serum levels of adiponectin in elderly patients with major depression. J Psychiatr Res (2012) 0.92
Early intervention in bipolar disorders: clinical, biochemical and neuroimaging imperatives. J Affect Disord (2008) 0.92
The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial. J Affect Disord (2011) 0.91
DNA damage in rats after treatment with methylphenidate. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.91
Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels. Basic Clin Pharmacol Toxicol (2008) 0.91
TNF-alpha, IL-1beta, IL-6, and cinc-1 levels in rat brain after meningitis induced by Streptococcus pneumoniae. J Neuroimmunol (2010) 0.90
Cognitive-behavioral group therapy in obsessive-compulsive disorder: a randomized clinical trial. Psychother Psychosom (2003) 0.90
Neurobiological correlates of illness progression in the recurrent affective disorders. J Psychiatr Res (2012) 0.90
Serum brain-derived neurotrophic factor in bipolar and unipolar depression: a potential adjunctive tool for differential diagnosis. J Psychiatr Res (2009) 0.90
The impact of staging bipolar disorder on treatment outcome of family psychoeducation. J Affect Disord (2009) 0.90
The role of BDNF as a mediator of neuroplasticity in bipolar disorder. Psychiatry Investig (2010) 0.89
Neurochemical and behavioural effects of acute and chronic memantine administration in rats: Further support for NMDA as a new pharmacological target for the treatment of depression? Brain Res Bull (2009) 0.89
Staging and neuroprogression in bipolar disorder: a systematic review of the literature. Rev Bras Psiquiatr (2013) 0.89
Memantine treatment reverses anhedonia, normalizes corticosterone levels and increases BDNF levels in the prefrontal cortex induced by chronic mild stress in rats. Metab Brain Dis (2012) 0.88
Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects. J Psychiatr Res (2013) 0.88
Tumor necrosis factor alpha (TNF-alpha) levels in the brain and cerebrospinal fluid after meningitis induced by Streptococcus pneumoniae. Neurosci Lett (2009) 0.88
Effects of mood stabilizers on DNA damage in an animal model of mania. J Psychiatry Neurosci (2008) 0.88
Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.87
The immunology of bipolar disorder. Neuroimmunomodulation (2014) 0.87
Resveratrol-loaded lipid-core nanocapsules treatment reduces in vitro and in vivo glioma growth. J Biomed Nanotechnol (2013) 0.87
Neuroprogression and Cognitive Functioning in Bipolar Disorder: A Systematic Review. Curr Psychiatry Rep (2015) 0.87
Mild cognitive impairment. Part 1: clinical characteristics and predictors of dementia. Rev Bras Psiquiatr (2013) 0.87
Course and outcome after the first manic episode in patients with bipolar disorder: prospective 12-month data from the Systematic Treatment Optimization Program For Early Mania project. Can J Psychiatry (2009) 0.86
Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: a positive correlation. Neurosci Lett (2011) 0.86
Reduced regulatory T cells are associated with higher levels of Th1/TH17 cytokines and activated MAPK in type 1 bipolar disorder. Psychoneuroendocrinology (2012) 0.86
Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients. Neurosci Lett (2009) 0.86
Circulating Glial-derived neurotrophic factor is reduced in late-life depression. J Psychiatr Res (2011) 0.86
Increased blood oxidative stress in experimental menopause rat model: the effects of vitamin A low-dose supplementation upon antioxidant status in bilateral ovariectomized rats. Fundam Clin Pharmacol (2011) 0.85
Using intravital microscopy to study the role of chemokines during infection and inflammation in the central nervous system. J Neuroimmunol (2010) 0.85
Increase in dopaminergic, but not serotoninergic, receptors in T-cells as a marker for schizophrenia severity. J Psychiatr Res (2012) 0.85
Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial. Hum Psychopharmacol (2009) 0.85
Neuroanatomical profile of antimaniac effects of histone deacetylases inhibitors. Mol Neurobiol (2011) 0.85
Effects of moderate exercise on cigarette smoke exposure-induced hippocampal oxidative stress values and neurological behaviors in mice. Neurosci Lett (2010) 0.84
Effects of beta-carboline harmine on behavioral and physiological parameters observed in the chronic mild stress model: further evidence of antidepressant properties. Brain Res Bull (2009) 0.84
Childhood trauma, impulsivity, and executive functioning in crack cocaine users. Compr Psychiatry (2011) 0.84
The role of chemokines in controlling granulomatous inflammation in Schistosoma mansoni infection. Acta Trop (2008) 0.84